A critical advance in cancer study is arising with the use of VHH fragments to reactivate damaged p53. This essential malignant inhibitor protein is frequently disabled in various forms of cancer, resulting https://rotatesites.com/story23529371/nanobodies-revive-p53-the-new-pathway-for-tumor-management